Gilead Sciences Announces Remarkable Collaboration With This Company

Groundbreaking Collaboration: Gilead Sciences and Compugen Announce Exclusive License Agreement.

In a remarkable display of collaboration and advancement in the field of immunotherapy, Gilead Sciences, Inc. and Compugen Ltd., two giants in the world of biopharmaceuticals, have announced an exclusive license agreement for a unique pre-clinical immunotherapy program.

Gilead Sciences, a research-based biopharmaceutical company that discovers, develops,…